SCA
EVH icon

Stonebridge Capital Advisors’s Evolent Health EVH Stock Holding History

Stonebridge Capital Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed – – 867
2019
Q3 		$0 Hold
20
– – ﹤0.01% 889
2019
Q2 		$0 Buy
+20
New +$237 ﹤0.01% 904

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Stonebridge Capital Advisors's EVH Position: Q4 2019 in Review

Stonebridge Capital Advisors sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 20 shares.

Stonebridge Capital Advisors first reported a position in EVH in Q2 2019 and held it in 2 quarters. The position peaked at $0 in Q3 2019. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

  • Stonebridge Capital Advisors reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 20 Evolent Health shares in Q4 2019.
  • Stonebridge Capital Advisors first reported a position in Evolent Health in Q2 2019 and held it in 2 quarters.
  • Stonebridge Capital Advisors's Evolent Health position peaked at $0 in Q3 2019.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.